Free Access
Issue
J Extra Corpor Technol
Volume 44, Number 1, March 2012
Page(s) 5 - 9
DOI https://doi.org/10.1051/ject/201244005
Published online 15 March 2012
  1. Nouette K, Richebé P, Calderon J, et al. Fonctions plaquettaires et risque hémorragique au cours de la circulation extracorporelle (CEC): La transfusion de plaquettes en chirurgie cardiaque. Sang Thrombose Vaisseaux. 2004;16:527–546. [Google Scholar]
  2. McGill N, O’Shaughnessy D, Pickering R, et al. Mechanical methods of reducing blood transfusion in cardiac surgery: Randomised controlled trial (published erratum appears in BMJ 2002;325:142). BMJ. 2002;324:1299–1305. [CrossRef] [PubMed] [Google Scholar]
  3. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet. 1999;354:1940–1947. [CrossRef] [PubMed] [Google Scholar]
  4. Boyle EMJr, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: The procoagulant response. Ann Thorac Surg. 1996;62:1549–1557. [CrossRef] [Google Scholar]
  5. Ray MJ, Hawson GA, Just SJ, et al. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass surgery. Ann Thorac Surg. 1997;57:981–986. [Google Scholar]
  6. Palanzo DA, Zarro DL, Manley NJ, et al. Effect of surface coating on platelet count drop during cardiopulmonary bypass. Perfusion. 1999;14:195–200. [CrossRef] [PubMed] [Google Scholar]
  7. Hope AF, Heyns AP, Lötter MG, et al. Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81:880–886. [CrossRef] [Google Scholar]
  8. Boonstra PW, van Imhoff GW, Eysman L, et al. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. J Thorac Cardiovasc Surg. 1985;89:900–906. [CrossRef] [Google Scholar]
  9. Despotis GJ, Goodnough LT. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg. 2000;70(Suppl):20S–32S. [Google Scholar]
  10. Slaughter TF, Sreeram G, Sharma AD, et al. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyser. Blood Coagul Fibrinolysis. 2001;12:85–93. [CrossRef] [PubMed] [Google Scholar]
  11. Ferraris VA, Ferraris SP, Singh A, et al. The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg. 1998;65:352–358. [CrossRef] [Google Scholar]
  12. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood. 1993;82:107–117. [CrossRef] [PubMed] [Google Scholar]
  13. De Somer F, Van Belleghem Y, Foubert L, et al. In vivo evaluation of a phosphorylcholine coated cardiopulmonary bypass circuit. J Extra Corpor Technol. 1999;31:62–66. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. De Somer F, Van Belleghem Y, Caes F, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion. 2002;17:39–44. [CrossRef] [PubMed] [Google Scholar]
  15. De Somer F, François K, van Oeveren W, et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg. 2000;18:602–606. [CrossRef] [PubMed] [Google Scholar]
  16. Myers GJ, Johnstone DR, Swyer WJ, et al. Evaluation of Mimesys® Phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults. J Extra Corpor Technol. 2003;35:6–12. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  17. Böning A, Scheewe J, Ivers T, et al. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants. J Thorac Cardiovasc Surg. 2004;127:1458–1465. [CrossRef] [Google Scholar]
  18. Pappalardo F, Della Valle P, Crescenzi G, et al. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: A randomized controlled trial. Ann Thorac Surg. 2006;81:886–891. [CrossRef] [Google Scholar]
  19. Aleil B, Wolff V, Wiesel M-L, et al. La glycoprotéine V soluble: Un nouveau marqueur de la thrombose artérielle. Médecine Thérapeutique Cardiologie. 2004;5:267–275. [Google Scholar]
  20. Schraw T, Whiteheart S. The development of a quantitative enzyme-linked immunosorbent assay to detect human platelet factor 4. Transfusion. 2005;45:717–724. [CrossRef] [PubMed] [Google Scholar]
  21. Hursting MJ, Butman BT, Steiner JP, et al. Monoclonal antibodies specific for prothrombin fragment 1.2 and their use in a quantitative enzyme-linked immunosorbent assay. Clin Chem. 1993;39:583–591. [CrossRef] [PubMed] [Google Scholar]
  22. Kjellberg M, Ikonomou T, Stenflo J. The cleaved and latent forms of antithrombin are normal constituents of blood plasma: A quantitative method to measure cleaved antithrombin. J Thromb Haemost. 2006;4:168–176. [CrossRef] [Google Scholar]
  23. Knudsen L, Hasenkam JM, Kure HH, et al. Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery. Thromb Res. 1996;84:45–54. [CrossRef] [Google Scholar]
  24. De Somer F, Van Belleghem Y, Caes F, et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002;123:951–958. [CrossRef] [Google Scholar]
  25. Chandler WL, Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood. 2003;101:4355–4362. [CrossRef] [PubMed] [Google Scholar]
  26. De Somer F, Van Belleghem Y, Caes F, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion. 2002;17:39–44. [CrossRef] [PubMed] [Google Scholar]
  27. Despotis GJ, Joist JH. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An update. J Cardiothorac Vasc Anesth. 1999;13:18–29. [CrossRef] [Google Scholar]
  28. Boneu B, Cazenave JP. Introduction à l’étude de l’hémostase et de la thrombose. Reims: Alinea Reims Editions Publicité; 1982:9–32. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.